International Clinical Trial: Prolonging dosing interval of adalimumab in patients with non-infectious uveitis: an open-label, non-inferiority, randomized clinical trial

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119928) titled 'Prolonging dosing interval of adalimumab in patients with non-infectious uveitis: an open-label, non-inferiority, randomized clinical trial' on March 5.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Condition: Non-infectious uveitis

Intervention: Experimental group:Subcutaneous adalimumab administration every three weeks

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-05

Target Sample Size: Experimental group:125;Control Group:125; ...